Immunic, Inc. Other Current Assets
Immunic, Inc. (IMUX) had Other Current Assets of $850.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-11
- 2026-06-30: Other Assets, Current $850.00K.
- 2026-03-31: Other Assets, Current $1.06M.
- 2025-12-31: Other Assets, Current $831.00K; Other Assets, Current as first filed $1.20M.
- 2025-09-30: Other Assets, Current $818.00K.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $850.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $1.06M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $831.00K 10-Q · filed 2026-08-11 | $1.20M 10-K · filed 2026-02-26 |
| 2025-09-30 | $818.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $861.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.25M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.11M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $757.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.06M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.09M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.07M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.45M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.39M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $1.90M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.23M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $1.55M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $1.52M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $1.55M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $1.12M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $1.27M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.50M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $886.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $1.23M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $597.00K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $655.00K 10-Q · filed 2020-08-03 | |
| 2020-03-31 | $670.00K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $796.00K 10-K · filed 2021-02-26 | |
| 2018-12-31 | $68.00K 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |